Ironwood Pharmaceuticals Inc (NAS:IRWD)
$ 4.495 0.305 (7.28%) Market Cap: 718.03 Mil Enterprise Value: 1.21 Bil PE Ratio: 112.38 PB Ratio: 0 GF Score: 51/100

Ironwood Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 10:20PM GMT
Release Date Price: $11.63 (-1.94%)
Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst

All right. Good evening, and thanks again for joining us for the annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst at the firm. Our next presenting company is Ironwood Pharmaceuticals, and it's my pleasure to welcome the CEO, Mark Mallon, to tell us a little bit about the company.

Before I hand it over, I just want to remind folks that they can ask a question that I will ask on their behalf in the Q&A session after the presentation. (Operator Instructions) So with that, Mark, thanks again for sharing some of your time with us. Take it away.

Mark Mallon
Ironwood Pharmaceuticals, Inc. - CEO & Director

Great. Thanks, Eric, and thanks to all the participants. I also want to say thanks to JPMorgan for hosting the event. I have to say they've done a great job in transitioning from an in-live event to this virtual platform. We had a great day today, having a chance to meet with a number of important investors and other important

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot